Mercury Laboratories Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 287757, "name": "Mercury Labs", "stock_name": "Mercury Labs", "full_name": "Mercury Laboratories Ltd", "name_url": "stocks-analysis/mercury-labs", "exchange": 0, "exchangecode": "", "primexch": 0, "country_id": 34, "currency": "INR", "cmp": "755.05", "chg": -33.95, "chgp": "-4.3%", "dir": -1, "prev_price": "789.00", "mcapval": "91.00 Cr", "mcap": "Micro Cap", "scripcode": 538964, "symbol": "", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "India SENSEX", "isin": "INE947G01011", "curr_date": "May 12", "curr_time": "", "bse_nse_vol": "12 ", "exc_status": "Active", "traded_date": "May 12, 2026", "traded_date_str": "2026 05 12", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/mercury-labs-287757-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Mercury Laboratories Ltd Upgraded to Sell on Technical Improvement and Valuation Appeal", "link": "https://www.marketsmojo.com/news/stock-recommendation/mercury-laboratories-ltd-upgraded-to-sell-on-technical-improvement-and-valuation-appeal-3980916", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/MercuryLaborato_mojoScore_3980916.png", "date": "2026-05-08 08:10:30", "description": "Mercury Laboratories Ltd has seen its investment rating upgraded from Strong Sell to Sell, reflecting a nuanced shift in its technical outlook amid mixed financial and valuation metrics. While the company’s recent quarterly performance shows promise, long-term fundamentals and market returns continue to weigh on investor sentiment." }, { "title": "Mercury Laboratories Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/mercury-laboratories-ltd-is-rated-strong-sell-3972545", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/MercuryLaborato_mojoScore_3972545.png", "date": "2026-05-02 10:10:38", "description": "Mercury Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 27 Mar 2026. However, the analysis and financial metrics presented here reflect the stock’s current position as of 02 May 2026, providing investors with the latest insights into its performance and outlook." }, { "title": "Mercury Laboratories Ltd Falls to 52-Week Low of Rs 620.55 as Sell-Off Deepens", "link": "https://www.marketsmojo.com/news/stocks-in-action/mercury-laboratories-ltd-falls-to-52-week-low-amid-market-downturn-3961239", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/MercuryLaborato_priceRelatedfactors_3961239.png", "date": "2026-04-24 15:35:09", "description": "A sharp decline of 19.41% intraday has dragged Mercury Laboratories Ltd to a fresh 52-week low of Rs 620.55 on 24 Apr 2026, marking a significant setback for the micro-cap pharmaceutical player amid a broadly weak market environment." }, { "title": "Mercury Laboratories Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/mercury-laboratories-ltd-is-rated-strong-sell-3955695", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/MercuryLaborato_mojoScore_3955695.png", "date": "2026-04-21 10:10:52", "description": "Mercury Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 27 March 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 21 April 2026, providing investors with an up-to-date view of the company's fundamentals, valuation, financial trends, and technical outlook." }, { "title": "Mercury Laboratories Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/mercury-laboratories-ltd-is-rated-strong-sell-3941370", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/MercuryLaborato_mojoScore_3941370.png", "date": "2026-04-10 10:10:57", "description": "Mercury Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 27 March 2026. However, the analysis and financial metrics presented here reflect the stock’s current position as of 10 April 2026, providing investors with the latest insights into the company’s performance and outlook." }, { "title": "Mercury Laboratories Ltd Falls 1.23%: 4 Key Factors Driving the Weekly Decline", "link": "https://www.marketsmojo.com/news/stocks-in-action/mercury-laboratories-ltd-falls-123-4-key-factors-driving-the-weekly-decline-3932429", "imagepath": "", "date": "2026-04-05 11:00:03", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>Mar 30:</strong> New 52-week low recorded at Rs.700.05</p>\n <p><strong>Mar 30:</strong> Downgrade to Strong Sell by MarketsMOJO announced</p>\n <p><strong>Apr 1:</strong> Stock rebounds modestly to Rs.721.00 (+3.00%)</p>\n <p><strong>Apr 2:</strong> Stock holds steady at Rs.721.00 (0.00% change)</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.730.00</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.721.00</div><div class=\"stat-ch..." }, { "title": "Mercury Laboratories Ltd Falls to 52-Week Low of Rs 700.05 as Sell-Off Deepens", "link": "https://www.marketsmojo.com/news/stocks-in-action/mercury-laboratories-ltd-stock-hits-52-week-low-amidst-continued-downtrend-3924297", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/MercuryLaborato_priceRelatedfactors_3924297.png", "date": "2026-03-30 10:38:29", "description": "For the third consecutive session, Mercury Laboratories Ltd has seen its share price decline sharply, culminating in a fresh 52-week low of Rs 700.05 on 30 Mar 2026. This marks an 18.12% drop over the last three days, underscoring persistent selling pressure despite some positive financial indicators." }, { "title": "Mercury Laboratories Ltd Downgraded to Strong Sell Amid Bearish Technicals and Weak Fundamentals", "link": "https://www.marketsmojo.com/news/stock-recommendation/mercury-laboratories-ltd-downgraded-to-strong-sell-amid-bearish-technicals-and-weak-fundamentals-3923522", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/MercuryLaborato_mojoScore_3923522.png", "date": "2026-03-30 08:05:43", "description": "Mercury Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Sell to Strong Sell as of 27 Mar 2026. This shift reflects a deterioration in technical indicators alongside persistent fundamental weaknesses, despite some recent positive financial results. The company’s stock price has also suffered a sharp decline, underscoring investor caution amid mixed signals." }, { "title": "Five Consecutive Losses Push Mercury Laboratories Ltd to a New 52-Week Low", "link": "https://www.marketsmojo.com/news/stocks-in-action/mercury-laboratories-ltd-stock-falls-to-52-week-low-of-rs730-3919609", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/MercuryLaborato_priceRelatedfactors_3919609.png", "date": "2026-03-27 12:38:14", "description": "" } ], "total": 131, "sid": "287757", "stock_news_url": "https://www.marketsmojo.com/news/mercury-laboratories-287757" }, "announcements": [ { "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication", "datetime": "08-May-2026", "details": "Intimation of Newspaper advertisement regarding notice of transfer of shares to IEPFA and special window for dematerialization of physical transfer", "source": "BSE" }, { "caption": "Intimation To Shareholders Relating To Transfer Of Equity Shares To IEPF Authority", "datetime": "07-May-2026", "details": "Intimation to shareholder relating to transfer of Equity shares to IEPFA is attached", "source": "BSE" }, { "caption": "Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2", "datetime": "29-Apr-2026", "details": "<b>Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px> <tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr> <td>1</td> <td>Name of Company</td> <td>Mercury Laboratories Ltd</td> </tr> <tr> <td>2</td> <td>CIN NO.</td> <td>L74239MH1982PLC026341</td> </tr> <tr> <td>3</td> <td>Report filed for FY</td> <td>2025-2026</td> </tr> <tr><td colspan=3>Details of the Current block (all figures in Rs crore):</td><tr> <tr> <td>4</td> <td>2 - year block period (Specify financial years)* </td> <td>2025-26 26-27</td> </tr> <tr> <tr> <td>5</td> <td>Incremental borrowing done in FY (T)(a) </td> <td>0.00</td> </tr> <tr> <td>6</td> <td>Mandatory borrowing to be done through debt securities in FY (T) (b) = (25% of a)</td> <td>0.00</td> </tr> <tr> <td>7</td> <td>Actual borrowing done through debt securities in FY (T)(c)</td> <td>0.00</td> </tr> <tr> <td>8</td> <td> Shortfall in the borrowing through debt securities if any for FY (T - 1) carried forward to FY (T) (d)</td> <td>NA</td> </tr> <tr> <td>8</td><td>Quantum of (d) which has been met from (c)(e)*</td> <td>NA</td> </tr><tr> <td>9</td><td> Shortfall if any in the mandatory borrowing through debt securities for FY (T) { after adjusting for any shortfall in borrowing for FY(T - 1) which was carried forward to FY(T)}(f) = (b) - [(c) - (e)]{ If the calculated value is zero or negative write nil}*</td> <td>NA</td> </tr> </table> <br/><br/><table><tr><td colspan=2><b>Details of penalty to be paid if any in respect to previous block (all figures in Rs crore):</b></td></tr> <tr><td>2 - year Block period (Specify financial years)</td><td>2024-25 25-26</td></tr> <tr><td>Amount of fine to be paid for the block if applicable Fine = 0.2% of {(d) - (e)}#</td><td>0.00</td></tr> </table> <div> <br/><br/><br/> <table><tr><td>Name of the Company Secretary :-</td><td>Krishna Shah</td></tr><tr><td>Designation :-</td><td>Company Secretary and Compliance Officer</td></tr> <tr><td>Name of the Chief Financial Officer :- </td><td>Ashish Vasavada</td></tr> <tr><td>Designation : -</td><td>Chief Financial Officer</td></tr></table><div> <br/> Date: 29/04/2026<br/><br/></div>", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Mercury Laboratories Ltd has declared <strong>35%</strong> dividend, ex-date: 06 Aug 25", "dt": "2025-08-06", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

Mar 30: New 52-week low recorded at Rs.700.05

Mar 30: Downgrade to Strong Sell by MarketsMOJO announced

Apr 1: Stock rebounds modestly to Rs.721.00 (+3.00%)

Apr 2: Stock holds steady at Rs.721.00 (0.00% change)

Read full news article

Mercury Laboratories Ltd Falls to 52-Week Low of Rs 700.05 as Sell-Off Deepens

2026-03-30 10:38:29

For the third consecutive session, Mercury Laboratories Ltd has seen its share price decline sharply, culminating in a fresh 52-week low of Rs 700.05 on 30 Mar 2026. This marks an 18.12% drop over the last three days, underscoring persistent selling pressure despite some positive financial indicators.

Read full news article

Mercury Laboratories Ltd Downgraded to Strong Sell Amid Bearish Technicals and Weak Fundamentals

2026-03-30 08:05:43

Mercury Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Sell to Strong Sell as of 27 Mar 2026. This shift reflects a deterioration in technical indicators alongside persistent fundamental weaknesses, despite some recent positive financial results. The company’s stock price has also suffered a sharp decline, underscoring investor caution amid mixed signals.

Read full news article

Five Consecutive Losses Push Mercury Laboratories Ltd to a New 52-Week Low

2026-03-27 12:38:14

Read full news article

Sr. No.	Particulars	Details
1	Name of Company	Mercury Laboratories Ltd
2	CIN NO.	L74239MH1982PLC026341
3	Report filed for FY	2025-2026
Details of the Current block (all figures in Rs crore):
4	2 - year block period (Specify financial years)*	2025-26 26-27
5	Incremental borrowing done in FY (T)(a)	0.00
6	Mandatory borrowing to be done through debt securities in FY (T) (b) = (25% of a)	0.00
7	Actual borrowing done through debt securities in FY (T)(c)	0.00
8	Shortfall in the borrowing through debt securities if any for FY (T - 1) carried forward to FY (T) (d)	NA
8	Quantum of (d) which has been met from (c)(e)*	NA
9	Shortfall if any in the mandatory borrowing through debt securities for FY (T) { after adjusting for any shortfall in borrowing for FY(T - 1) which was carried forward to FY(T)}(f) = (b) - [(c) - (e)]{ If the calculated value is zero or negative write nil}*	NA

Details of penalty to be paid if any in respect to previous block (all figures in Rs crore):
2 - year Block period (Specify financial years)	2024-25 25-26
Amount of fine to be paid for the block if applicable Fine = 0.2% of {(d) - (e)}#	0.00

Name of the Company Secretary :-	Krishna Shah
Designation :-	Company Secretary and Compliance Officer
Name of the Chief Financial Officer :-	Ashish Vasavada
Designation : -	Chief Financial Officer